| Flow and thixotropic parameters for rheological characterization of hydrogels MV Ghica, M Hîrjău, D Lupuleasa, CE Dinu-Pîrvu Molecules 21 (6), 786, 2016 | 141 | 2016 |
| Chitosan-based in situ gels for ocular delivery of therapeutics: a state-of-the-art review T Irimia, CE Dinu-Pîrvu, MV Ghica, D Lupuleasa, DL Muntean, DI Udeanu, ... Marine drugs 16 (10), 373, 2018 | 117 | 2018 |
| Development and evaluation of new microemulsion-based hydrogel formulations for topical delivery of fluconazole G Coneac, V Vlaia, I Olariu, AM Muţ, DF Anghel, C Ilie, C Popoiu, ... Aaps Pharmscitech 16, 889-904, 2015 | 83 | 2015 |
| Cellulose-derivatives-based hydrogels as vehicles for dermal and transdermal drug delivery L Vlaia, G Coneac, I Olariu, V Vlaia, D Lupuleasa Emerging concepts in analysis and applications of hydrogels 2, 64, 2016 | 77 | 2016 |
| Enhancement of solubility and dissolution rate of different forms of atorvastatin calcium in direct compression tablet formulas SW Ahjel, D Lupuleasa Farmacia 57 (3), 290-300, 2009 | 56 | 2009 |
| Development, optimization and in vitro/in vivo characterization of collagen-dextran spongious wound dressings loaded with flufenamic acid MV Ghica, MG Albu Kaya, CE Dinu-Pîrvu, D Lupuleasa, DI Udeanu Molecules 22 (9), 1552, 2017 | 52 | 2017 |
| Pelletization techniques used in pharmaceutical fields M Hirjau, AC Nicoara, V Hirjau, D Lupuleasa Practica Farmaceutica 4 (3), 206-211, 2011 | 42 | 2011 |
| New opportunity to formulate intranasal vaccines and drug delivery systems based on chitosan R Popescu, MV Ghica, CE Dinu-Pîrvu, V Anuța, D Lupuliasa, L Popa International Journal of Molecular Sciences 21 (14), 5016, 2020 | 40 | 2020 |
| The Age of Pharmaceutical 3D Printing. Technological and Therapeutical Implications of Additive Manufacturing. IB Dumitrescu, D Lupuliasa, C DRĂGOI, AC NICOLAE, A Pop, ... Farmacia 66 (3), 2018 | 38 | 2018 |
| INSIGHTS INTO CHRONONUTRITION: THE INNERMOST INTERPLAY AMONGST NUTRITION, METABOLISM AND THE CIRCADIAN CLOCK, IN THE CONTEXT OF EPIGENETIC REPROGRAMMING. C DRĂGOI, E MOROŞAN, IB Dumitrescu, AC NICOLAE, AL ARSENE, ... Farmacia 67 (4), 2019 | 34 | 2019 |
| A NEW ERA FOR THE THERAPEUTIC MANAGEMENT OF THE ONGOING COVID-19 PANDEMIC. AL ARSENE, IB Dumitrescu, C DRĂGOI, DI Udeanu, D Lupuliasa, V Jinga, ... Farmacia 68 (2), 2020 | 29 | 2020 |
| Modern aspects regarding the microbial spoilage of pharmaceutical products OH Kamil, D Lupuliasa Farmacia 59 (2), 133-46, 2011 | 29 | 2011 |
| Investigation of cyclodextrin based nanosponges complexes with angiotensin I converting enzyme inhibitors (Enalapril, captopril, cilazapril) AA Olteanu, CC Arama, C Bleotu, D Lupuleasa, CM Monciu Farmacia 63 (492-503), 1, 2015 | 28 | 2015 |
| Escaping the economic turn down through performing employees, creative leaders and growth driver capabilities in the Romanian pharmaceutical industry MP Raţiu, I Purcărea, F Popa, VL Purcărea, TV Purcărea, D Lupuleasa, ... Farmacia 59 (1), 119-130, 2011 | 27 | 2011 |
| Cardiovascular risk assessment in osteoporotic patients using osteoprotegerin as a reliable predictive biochemical marker CG Barbu, AL Arsene, S Florea, A Albu, A Sirbu, S Martin, AC Nicolae, ... Molecular Medicine Reports 16 (5), 6059-6067, 2017 | 23 | 2017 |
| The polyphenolic profile and antioxidant activity of five vegetal extracts with hepatoprotective potential L Costea, CL Chițescu, R Boscencu, M Ghica, D Lupuliasa, DP Mihai, ... Plants 11 (13), 1680, 2022 | 21 | 2022 |
| Terminologie medicală şi farmaceutică L Ochiuz, I Popovici, D Lupuleasa, V Rusu Polirom, 2011 | 21 | 2011 |
| Tehnologie farmaceutică: Forme farmaceutice ca sisteme disperse eterogene. Forme farmaceutice ca dispersii ultramicroeterogene. Forme farmaceutice ca dispersii microeterogene I Popovici, D Lupuleasa, V Stănescu Polirom, 2008 | 21* | 2008 |
| Evidence of strong opioid therapy for palliation of breathlesness in cancer patients AN Ciuhu, RA Rahnea Nita, M Popescu, CD Badiu, AM Pantea Stoian, ... Farmacia 65 (2), 173-178, 2017 | 20 | 2017 |
| Physico-chemical and pharmaco-technical characterization of inclusion complexes formed by rutoside with β-cyclodextrin and hydroxypropyl-β-cyclodextrin used to develop solid … T Balaci, B Velescu, O Karampelas, AM Musuc, GM Nițulescu, EA Ozon, ... Processes 9 (1), 26, 2020 | 19 | 2020 |
